Immunotherapy and warts: a point of view

Clinics in Dermatology

Volumn 26, Issue 2, 2008, Pages 223-225

  Goihman Yahr, Mauricio ^a   Goldblum, Orin M ^b  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; BCG VACCINE; CANDIDIN; CIMETIDINE; DIPHENCYPRONE; IMIQUIMOD; IMMUNOSUPPRESSIVE AGENT; INTERFERON; LEVAMISOLE; SQUARIC ACID DIBUTYL ESTER; TRIAZIQUONE; TRICHOPHYTIN; TUBERCULIN; VIRUS ANTIGEN;

ARTICLE; CRYOTHERAPY; ELECTROSURGERY; HUMAN; IMMUNOTHERAPY; IN VITRO STUDY; INFECTION; NONHUMAN; PAPOVAVIRUS; PRIORITY JOURNAL; VERRUCA VULGARIS;

HUMANS; IMMUNOTHERAPY; WARTS;

EID: 42949163438     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2007.10.011     Document Type: Article

References (21)

1. Breitburd F., Salmon J., and Orth G. The rabbit viral skin papillomas and carcinomas: a model for the immunogenetics of HPV-associated carcinogenesis. Clin Dermatol 15 (1997) 237-247
2. Purdie K.J., Surentheran T., Sterling J.C., et al. Human papillomavirus gene expression in cutaneous squamous cell carcinomas from immunosuppresed and immunocompetent individuals. J Invest Dermatol 125 (2005) 98-107
3. Forslund O., Lindelof B., Hradil E., et al. High prevalence of cutaneous human papillomavirus DNA on the top of skin tumors but not in stripped biopsies from the same tumors. J Invest Dermatol 123 (2004) 388-394
4. Goihman-Yahr M., and Essenfeld-Yahr E. Verrugas e Inmunidad (Informe de un Caso de Desaparición Espontánea de Verrugas Planas con Documentación Histopatológica) Warts and immunity (report of a case of spontaneous disappearance of flat warts and its pathology). Med Cutan Ibero Lat Am 6 (1972) 47-50
5. Goihman Yahr M., Fernandez J., and Convit J. Inmunoterapia de las Verrugas Vulgares Diseminadas con Dinitroclorobenceno (Immunotherapy of disseminated common warts with dinitrochiorobenzene). Med Cutan Ibero Lat Am 4 (1976) 187-193
6. Goihman-Yahr M., Fernandez J., Boatswain A., et al. Unilateral dinitrochlorobenzene immunopathy of recalcitrant warts. Lancet 311 (1978) 447-448
7. Vandepapeliere P., Barrasso R., Meijer C.J., et al. Randomized controlled trial of an adjuvanted human papillomavirus (HPV) type 6 L2E7 vaccine: infection of external anogenital warts with multiple HPV types and failure of therapeutic vaccination. J Infect Dis 192 (2005) 2099-2107
8. Lozada-Nur F., Glick M., Schubert M., et al. Use of intralesional interferon-alpha for the treatment of recalcitrant oral warts in patients with AIDS: a report of 4 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92 (2001) 617-622
9. Syed T.A., and Ahmadpour O.A. Human leukocyte derived interferon-alpha in a hydrophilic gel for the treatment of intravaginal warts in women: a placebo-controlled, double-blind study. Int J STD AIDS 9 (1998) 769-772
10. Sauder D.N. Mechanism of action and emerging role of immune response modifier therapy in dermatologic conditions. J Cutan Med Surg 8 Suppl 3 (2004) 3-12
11. Rechtsteiner G., Warger T., Osterloh P., et al. Cutting edge: priming of CTL by transcutaneous peptide immunization with imiquimod. J Immunol 174 (2005) 2476-2480
12. Arany I., Tyring S.K., Stanley M.A., et al. Enhancement of the innate and cellular immune response in patients with genital warts treated with topical imiquimod cream 5%. Antivir Res 43 (1999) 55-63
13. Horn T.D., Johnson S.M., Helm R.M., et al. Intralesional immunotherapy of warts with mumps, Candida, and Trichophytin skin test antigens: a single-blinded, randomized, and controlled trial. Arch Dermatol 141 (2005) 589-594
14. Higgins E., and du Vivier A. Topical immunotherapy: unapproved uses, dosages, or indications. Clin Dermatol 20 (2002) 515-521
15. Aghaei S. Treatment of disseminated facial warts through contact immunotherapy with diphenylcyclopropenone (DPCP). Dermatol Online J 12 (2006) 10
16. Dall 'Oglio F., Nasca M.R., D'Agata O., et al. Adult and paediatric contact immunotherapy with squaric acid dibutylester (SADBE) for recurrent, multiple, resistant, mucocutaneous anogenitai warts. Sex Transm Infect 78 (2002) 309-310
17. Haedersdal M., Selvaag E., and Petersen C.S. Immunotherapy with diphenylcyclopropenone of recalcitrant warts: a retrospective analysis. Acta Derm Venereol 80 (2000) 217-218
18. Silverberg N.B., Lim J.K., Paller A.S., et al. Squaric acid immunotherapy for warts in children. J Am Acad Dermatol 42 (2000) 803-808
19. Epstein W.L., and Strieker R.B. Immunomodulation by allergic contact sensitization: the dinitrochlorobenzene story. Am J Contact Dermat 6 (1995) 117-121
20. Strieker R.B., and Goldberg B. Safety of topical dinitrochlorobenzene. Lancet 346 (1995) 1293
21. Goihman-Yahr M. Combined immunotherapy of recalcitrant warts. Int J Dermatol 45 (2006) 627